ABOUT THE ROLE
At DSV we’re looking for future Founders, entrepreneurially minded individuals with industryspecific technical and commercial domain expertise eager to solve urgent unmet challenges through venture building.
You will join DSV’s venture creation programme as a Founder in Residence and work closely with the DSV team, using our methodology, to spinout a new company. During the programme, you’ll work on all aspects related to venture creation in this opportunity area, including working out the optimal approach to solve for the desired outcome, building a team and building a viable business case. Once the new venture is incorporated with preseed investment from DSV, you and your cofounders will own the majority stake in the business and continue receiving support from the DSV team postspinout.
The role is fulltime, fully remote until venture incorporation and spinout, after TBD.
Preferred (nicetohave):
Benefits
OUR OFFER
By joining DSV, you’ll be joining a team of operators who have founded companies and led translation of science at some of the most respected universities, charities, funds and government agencies. 23 of the team have founded or led a company at Csuite and 65% have a PhD. Our team dedicate several hours every week to each Founderfounding team to provide tailored guidance, resources and feedback covering every aspect of what it takes to successfully launch a new venture from both the tech and commercial perspectives:
WHO YOULL BE JOINING
You will be joining Dr. Kiren BainesMortimore, an accomplished scientific leader with many years of experience across drug discovery and development. Kiren, is the former cofounder and CSO at Extracellular, a cultivated meat CDMO. Prior to founding Extracellular, Kiren was the Analytical Development and Quality Control Lead at eXmoor Pharma,where she supported clients in the cell and gene therapy sector with process and analytical development, manufacturing, and commercialization. Earlier in her career, Kiren contributed to drug discovery initiatives at Charles River Laboratories. Kiren earned her PhD in Cell Biology from the University of Bristol. Kiren’s background in Parkinson’s combined with her expertise in drug development, along with her outstanding professionalism and ambition, makes her a top talent to work with.
ABOUT DSV
Deep Science Ventures is creating a future in which both humans and the planet can thrive.
We use our unique venture creation process to create, spinout and invest into science companies, combining available scientific knowledge and foundertype scientists into highimpact ventures.
We operate in 4 sectors: Pharmaceuticals, Climate, Agriculture and Computation, tackling the challenges defining those areas by taking a first principles approach and partnering with leading institutions.
ABOUT OUR PARTNERSHIP WITH PARKINSONS UK
In a landmark collaboration that marries scientific prowess with an unwavering dedication to improving patient lives, Deep Science Ventures, an avantgarde venture creator headquartered in London, has announced a pioneering partnership with Parkinson’s UK, the leading charity driving better care, treatments, and quality of life for those affected by Parkinson’s.
K2 Integrity
GuidePoint Security
Seedify
Chestnut
biBerk Business Insurance